Different medical institutions have selected different imported and domestic brand instruments: 38 domestic and 58 imported.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

The proposed acquisition comes shortly after a court ordered Hill-Rom to complete its acquisition of Bardy Diagnostics, a cardiac monitoring specialist, for $375 million.

According to "Medical Device and Diagnostics Contract Research Organization Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type and Services and Geography", the market is expected to reach US$ 20,336.08 million in 2028 from US$ 12,314.65 million in 2021.

QIAGEN to join the DAX on September 20, 2021, the effective date for changes in index composition. QIAGEN to remain in TecDAX comprised of the 30 largest German technology sector companies.

Mindray has purchased 3,048,662 shares through the stock repurchase special securities account, accounting for 0.2508% of the total share capital of the company. The total amount paid is almost 1 Billon CNY.

China has announced plans to set up a third stock exchange to serve small and medium-sized businesses.

Digital health technology firm Cue Health is seeking up to $100 million in a proposed initial public offering, it said in a registration statement filed on Wednesday with the US Securities and Exchange Commission.

Belgian molecular diagnostics maker Biocartis on Thursday reported a 31 percent year-over-year increase in revenues for the first half of 2021 on strong sales of its Idylla system and related test cartridges.

August 20, the Hurun Research Institute in association with Jiaxing City released the 2021 Hurun Global 500.

BioMérieux reported sales growth of 7 percent for the first half of 2021.The Marcy l'Etoile, France-based diagnostics firm reported total sales of €1.57 billion ($1.86 billion) for the six-month period ended June 30, 2020, up from €1.48 billion for the first half of 2020.

Seegene said Wednesday that it has obtained CE marking for the use of its Combo Swab self-collection device with four of the firm's SARS-CoV-2 molecular diagnostic assays, enabling its use in the EU and other regions that accept the designation.